StockWatch
·
Pharmaceuticals
Board Meeting26 May 2026, 04:52 pm

Fermenta Biotech: Director Re-Appointment, ESOP Grant, NSE Application

AI Summary

Fermenta Biotech Ltd's board approved the re-appointment of Ms. Rajeshwari Datla as a Non-Executive Director, subject to member approval. The Compensation Committee approved granting 3,95,400 stock options under the FBL ESOP 2025 at an exercise price of ₹83.67 per option. The board also approved applying to the National Stock Exchange of India Limited for direct listing and trading of equity shares. Additionally, in-principle approval was granted to Fermenta Environment Solutions Private Limited (FESPL) for a private placement of equity shares and an employee stock option plan.

Key Highlights

  • Rajeshwari Datla's re-appointment as Non-Executive Director approved, subject to shareholder approval.
  • 3,95,400 stock options granted to employees under FBL ESOP 2025 at ₹83.67 per option.
  • Fermenta Biotech to apply for direct listing on the National Stock Exchange of India Limited.
  • FESPL granted in-principle approval for private placement of equity shares.
  • FESPL also approved for implementing an Employee Stock Option Plan 2026.